ASEGUA THERAPEUTICS LLC recalls Sofosbuvir and Velpatasvir
- Published
- 16 Apr 2025
- Units affected
- 18,541 cartons.
- Agency
- FDA
- Country
- United States
The hazard
Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx Only, Manufactured for: Asegua Therapeutics LLC an affiliate of Gilead Sciences, Inc., Foster City, CA 94404, Made in Ireland, NDC# 72626-2701-1
- Brand / company
- ASEGUA THERAPEUTICS LLC
- Codes / lots
- Lot# 24ASV002UA, Exp Date: 6/30/2028
- Distribution
- US Nationwide
- Recall status
- Terminated
Source: U.S. Food and Drug Administration, published 16 Apr 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.